Optimal gastric cancer patients cancer patient selection. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Serous Membrane Gastric Mucosa Cell Line, Tumor Stomach Lymph Nodes Cytokine-Induced Killer Cells Rectus Abdominis Tumor Cells, Cultured Neoplastic Cells, Circulating Neoplastic Stem Cells Cardia Breast

Organisms3

Helicobacter pylori Mice, Nude Mice, Inbred BALB C

Diseases50

Stomach Neoplasms Adenocarcinoma Peritoneal Neoplasms Lymphatic Metastasis Neoplasm Metastasis Breast Neoplasms Neoplasms Neoplasm Invasiveness Helicobacter Infections Carcinoma, Signet Ring Cell Lung Neoplasms Neoplasm Recurrence, Local Carcinoma Prostatic Neoplasms Genetic Predisposition to Disease Disease Progression Colorectal Neoplasms Ovarian Neoplasms Colonic Neoplasms Metaplasia Liver Neoplasms Pancreatic Neoplasms Gastritis, Atrophic Gastrointestinal Neoplasms Gastritis Carcinoma, Non-Small-Cell Lung Adenocarcinoma, Mucinous Carcinoma, Squamous Cell Rectal Neoplasms Uterine Cervical Neoplasms Esophageal Neoplasms Urinary Bladder Neoplasms Postoperative Complications Precancerous Conditions Cell Transformation, Neoplastic Head and Neck Neoplasms Neoplastic Cells, Circulating Neovascularization, Pathologic Endometrial Neoplasms Bone Neoplasms Adenocarcinoma, Scirrhous Neoplasms, Second Primary Mouth Neoplasms Genital Neoplasms, Female Carcinoma, Small Cell Recurrence Neoplasms, Multiple Primary Neoplasms, Hormone-Dependent Neoplasms, Glandular and Epithelial Kidney Neoplasms

Chemicals and Drugs52

Tumor Markers, Biological Fluorouracil Oxonic Acid Antineoplastic Agents Cisplatin Carcinoembryonic Antigen Neoplasm Proteins Tegafur RNA, Messenger Leucovorin Organoplatinum Compounds Thymidylate Synthase Lentinan Receptor, erbB-2 Picibanil DNA, Neoplasm Cadherins Taxoids Cancer Vaccines Tumor Suppressor Protein p53 Paclitaxel Drug Combinations Vascular Endothelial Growth Factor A Receptors, Estrogen Glutathione S-Transferase pi Antigens, Neoplasm RNA, Small Interfering Antibodies, Monoclonal Antineoplastic Agents, Phytogenic Keratin-20 Prostate-Specific Antigen Tamoxifen DNA-Binding Proteins Endonucleases Receptor, Epidermal Growth Factor Antibodies, Monoclonal, Humanized Antineoplastic Agents, Hormonal Antimetabolites, Antineoplastic Receptors, Progesterone MicroRNAs Pepsinogen A Deoxycytidine Tumor Suppressor Proteins Protein Kinase Inhibitors Quinazolines RNA, Neoplasm Camptothecin Anticarcinogenic Agents DNA Primers Transcription Factors Proto-Oncogene Proteins Epirubicin

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Gastrectomy Patient Selection Prognosis Neoplasm Staging Treatment Outcome Survival Rate Retrospective Studies Survival Analysis Antineoplastic Combined Chemotherapy Protocols Kaplan-Meier Estimate Peritoneal Lavage Follow-Up Studies Lymph Node Excision Early Detection of Cancer Chemotherapy, Adjuvant Immunohistochemistry Risk Factors Disease-Free Survival Prospective Studies Multivariate Analysis Reverse Transcriptase Polymerase Chain Reaction Predictive Value of Tests Combined Modality Therapy Case-Control Studies Gene Expression Profiling Risk Assessment Sensitivity and Specificity Polymerase Chain Reaction Clinical Trials as Topic Drug Administration Schedule Chi-Square Distribution Blotting, Western Proportional Hazards Models Risk Registries ROC Curve Jejunostomy Enzyme-Linked Immunosorbent Assay Biopsy Cohort Studies Odds Ratio Immunoenzyme Techniques Reproducibility of Results Xenograft Model Antitumor Assays Molecular Targeted Therapy Logistic Models Questionnaires Neoplasm Transplantation Gastroscopy Oligonucleotide Array Sequence Analysis Tomography, X-Ray Computed Incidence Tumor Burden Palliative Care Radiotherapy, Adjuvant Transplantation, Heterologous Tissue Array Analysis Postoperative Period Feasibility Studies Immunotherapy Neoplasm Grading Transfection Radiotherapy Flow Cytometry Models, Biological Preoperative Care SEER Program Clinical Trials, Phase I as Topic Drug Screening Assays, Antitumor Radiotherapy Dosage Positron-Emission Tomography Models, Genetic Confidence Intervals Prostatectomy DNA Mutational Analysis Mastectomy Regression Analysis Mammography Endoscopy Research Design Real-Time Polymerase Chain Reaction Clinical Trials, Phase III as Topic

Psychiatry and Psychology1

Phenomena and Processes45

Selection, Genetic Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Genotype Time Factors Polymorphism, Genetic DNA Methylation Sensitivity and Specificity Drug Resistance, Neoplasm Mutation Chi-Square Distribution Risk Down-Regulation Promoter Regions, Genetic Odds Ratio Cell Proliferation Apoptosis Gene Expression Base Sequence Cell Movement Polymorphism, Single Nucleotide Phenotype Cell Survival Dose-Response Relationship, Drug Alleles Up-Regulation Signal Transduction Cell Division Germ-Line Mutation Transfection Cell Cycle RNA Interference Gene Silencing Cell Growth Processes Genes, BRCA1 Genes, Tumor Suppressor Genes, p53 Genetic Variation Genes, Neoplasm Microsatellite Repeats Algorithms CpG Islands Diet Gene Amplification Loss of Heterozygosity

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Research Design

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Teaching Rounds National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Questionnaires Base Sequence Molecular Sequence Data Incidence SEER Program Algorithms

Named Groups2

Asian Continental Ancestry Group Survivors

Health Care38

Patient Selection Treatment Outcome Survival Rate Retrospective Studies Survival Analysis Kaplan-Meier Estimate Follow-Up Studies Risk Factors Disease-Free Survival Prospective Studies Multivariate Analysis Predictive Value of Tests Case-Control Studies Risk Assessment Sensitivity and Specificity Clinical Trials as Topic Chi-Square Distribution Proportional Hazards Models Age Factors Risk Registries ROC Curve Cohort Studies Odds Ratio Reproducibility of Results Logistic Models Questionnaires Incidence National Cancer Institute (U.S.)Palliative Care Postoperative Period Feasibility Studies Preoperative Care SEER Program Clinical Trials, Phase I as Topic Confidence Intervals Regression Analysis Clinical Trials, Phase III as Topic

Geographicals5

China Japan Iran United States Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Stomach Neoplasms Gastrectomy Patient Selection Prognosis Adenocarcinoma Neoplasm Staging Tumor Markers, Biological Treatment Outcome Selection, Genetic Survival Rate Peritoneal Neoplasms Retrospective Studies Survival Analysis Fluorouracil Lymphatic Metastasis Neoplasm Metastasis Breast Neoplasms Antineoplastic Combined Chemotherapy Protocols Neoplasms Gene Expression Regulation, Neoplastic Helicobacter pylori Neoplasm Invasiveness Kaplan-Meier Estimate Helicobacter Infections Serous Membrane Carcinoma, Signet Ring Cell Peritoneal Lavage Follow-Up Studies Oxonic Acid Lymph Node Excision Early Detection of Cancer Antineoplastic Agents Gastric Mucosa Cell Line, Tumor Cisplatin Lung Neoplasms Chemotherapy, Adjuvant Immunohistochemistry Neoplasm Recurrence, Local Risk Factors Carcinoembryonic Antigen Disease-Free Survival Prospective Studies Carcinoma Multivariate Analysis Neoplasm Proteins Prostatic Neoplasms Tegafur Reverse Transcriptase Polymerase Chain Reaction Genetic Predisposition to Disease Disease Progression Colorectal Neoplasms China Stomach Predictive Value of Tests Ovarian Neoplasms Combined Modality Therapy RNA, Messenger Leucovorin Genotype Organoplatinum Compounds Case-Control Studies Time Factors Thymidylate Synthase Lentinan Gene Expression Profiling Polymorphism, Genetic Receptor, erbB-2 Colonic Neoplasms DNA Methylation Metaplasia Mice, Nude Picibanil Lymph Nodes DNA, Neoplasm Liver Neoplasms Pancreatic Neoplasms Gastritis, Atrophic Cadherins Risk Assessment Sensitivity and Specificity Drug Resistance, Neoplasm Gastrointestinal Neoplasms Japan Polymerase Chain Reaction Clinical Trials as Topic Mutation Taxoids Gastritis Asian Continental Ancestry Group Drug Administration Schedule Cancer Vaccines Carcinoma, Non-Small-Cell Lung Chi-Square Distribution Tumor Suppressor Protein p53 Blotting, Western Adenocarcinoma, Mucinous Proportional Hazards Models Age Factors Cytokine-Induced Killer Cells

No FAQ available that match "optimal gastric cancer patients cancer patient selection"